Abivax SA ABVX
EURONEXT · France · Health Technology
€84.15-3.65 (-4.16%)
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-09-21 | -1.47 | -0.61 | -141.0% | €1.20M | +72.1% | -5.1%€91.00→€86.40 |
| Q1 2026 | 2026-05-22 | -0.61 | -0.85 | +28.2% | — | — | +9.5%€105.10→€115.10 |
| Q4 2025 | 2026-03-23 | -2.66 | -0.98 | -171.4% | — | — | -11.0%€109.40→€97.40 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.